Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
A clinical study is recruiting to evaluate local ablative therapy for oligoprogressive non-small cell lung cancer in patients receiving firs…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment [Phase 2]
Phase 2 clinical trial investigating SHR-A1921 combined with adebrelimab for advanced non-small cell lung cancer in patients who failed prio…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
A clinical study evaluating the role and impact of wearable smart devices for perioperative care in patients with non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating LM-108 antibody in combination with sintilimab for locally advanced or metastatic non-small cell lung ca…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer
A clinical trial update describing an active-not-recruiting study from Ruijin Hospital evaluating radical surgery in patients with early-sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC [Phase 2]
A Phase 2 trial exploring neoadjuvant/adjuvant tislelizumab with anlotinib and platinum chemotherapy for resectable non-small cell lung canc…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer [NA]
This clinical trial is evaluating the combination of stereotactic radiotherapy (SRT) with anlotinib for brain metastases from non-small cell…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC [NA]
This registry entry describes a clinical study evaluating pembrolizumab in combination with microwave ablation (MWA) for advanced non-small …
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial update describes a phase 1/2 study of hypofractionated radiotherapy for locally advanced non-small cell lung cancer that is…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating TCR-T cell immunotherapy for non-small cell lung cancer and other solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC [EARLY_Phase 1]
An early Phase 1 clinical trial is recruiting for CXCR5-modified EGFR-targeted CAR-T cells to treat advanced non-small cell lung cancer, spo…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients [Phase 1, Phase 2]
A Phase 1b/2 clinical trial evaluating ABT-101 in advanced solid tumors and non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy [Phase 2]
A Phase II open-label, single-arm study evaluating cadonilimab (AK104) in combination with chemotherapy for advanced non-small cell lung can…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC [Phase 2]
Clinical trial update for SHR-A1921 or SHR-A2009 in previously treated advanced non-small cell lung cancer (Phase 2); the study is currently…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients [Phase 2]
Phase 2 clinical trial investigating a gallium-labeled imaging agent Ga-MMR-VHH2 for non-small cell lung cancer patients; recruitment curren…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: CPAP or BiPAP for Motion Mitigation During Radiotherapy [NA]
A University Medical Center Groningen trial is evaluating CPAP or BiPAP to mitigate motion during radiotherapy for NSCLC and other cancers, …
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC [Phase 3]
Phase 3 clinical trial update comparing ASK120067 to Gefitinib as first-line treatment for EGFR-mutant locally advanced or metastatic non-sm…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial update for SHR-A1811 in advanced non-small cell lung cancer (Phase 1/Phase 2). The study is sponsored by Jiangsu HengRui Me…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer
This clinical trial update discusses implementing TNM-immunoscore as a prognostic tool in patients with resected non-small cell lung cancer.…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. [Phase 2]
Phase 2 clinical trial update of Gumarontinib in combination with a third EGFR-TKI for non-small cell lung cancer; the study is not yet recr…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer [Phase 1]
This Phase 1 study is evaluating the combination of alisertib and osimertinib in patients with metastatic EGFR-mutant non-small cell lung ca…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating whether adding immune checkpoint inhibitors to platinum-based chemotherapy improves outcomes in EGFR/ALK/R…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy [Phase 2]
A Phase 2 clinical trial from Fudan University is evaluating treatment response adapted hybrid radiotherapy as first-line therapy for metast…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer
A clinical trial is evaluating whether adding immune checkpoint inhibitors to chemotherapy improves outcomes in non-small cell lung cancer. …
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer [Phase 2, Phase 3]
A clinical trial update reporting ongoing phase 2 and phase 3 studies evaluating the combination of anlotinib with immune checkpoint inhibit…